Compare Alliant Energy Corporation (LNT) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alliant Energy Corporation vs Novo Nordisk A/S — how do they compare? Alliant Energy Corporation trades at $70.15 (market cap $17.78B), while Novo Nordisk A/S trades at $46.28 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 11.7× Alliant Energy Corporation's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| LNT | NVO | |
|---|---|---|
Market Cap | $17.78B | $207.85B |
Sector | Utilities | Health |
52-Week High | $78.03 | $63.98 |
52-Week Low | $63.62 | $35.29 |
Enterprise Value | $29.88B | $222.55B |
Dividend Yield | 3.12% | 3.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LNT trades at $70.25, up 2.98% today, with a bearish technical signal but strong fundamentals including a P/E of 21.7 and net income margin of 18.45%. Recent Q2 2026 earnings of $0.65 per share missed some estimates but beat others, with revenue growth supported by data center demand. The stock is near support at $68, with analyst consensus bullish and a $77.67 price target.
Outlook is positive due to consistent earnings beats, dividend yield, and institutional interest, but risks include high debt levels and competitive pressures. Investors may find value in its stable cash flow and growth in utility demand, though technical weakness suggests cautious entry near support levels.
Novo Nordisk (NVO) trades at $46.465, down 2.65% today, with a neutral technical signal. The stock shows strong fundamentals, including a P/E of 11.62, net income margin of 35.35%, and consistent earnings beats in recent quarters. Recent news highlights competitive pressures from Eli Lilly and mixed investor reactions to Q2 2026 results, despite an upwardly revised full-year outlook.
Outlook remains positive due to robust GLP-1 drug demand and profitability, but risks include pricing pressure and competition. Analysts are predominantly bullish (57.9% buy ratings), supporting a favorable long-term view despite near-term volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
